MARCHETTI, ANDREA
MARCHETTI, ANDREA
A prospective study on the early evaluation of response to androgen receptor-targeted agents with 11C-Choline, 68Ga-PSMA, and 18F-FACBC PET in metastatic castration-resistant prostate cancer: a single-center experience
2024 Mollica, V.; Marchetti, A.; Fraccascia, N.; Nanni, C.; Tabacchi, E.; Malizia, C.; Argalia, G.; Rosellini, M.; Tassinari, E.; Paccapelo, A.; Fanti, S.; Massari, F.
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis
2024 Rosellini, Matteo; Mollica, Veronica; Marchetti, Andrea; Coluccelli, Sara; Giunchi, Francesca; Tassinari, Elisa; Ricci, Costantino; Fiorentino, Michelangelo; Tallini, Giovanni; De Biase, Dario; Massari, Francesco
Clinical outcomes and prognostic factors in patients with penile carcinoma: a sub-analysis from Meet-URO 23 (I-RARE) registry study
2024 Mollica, Veronica; Massari, Francesco; Maruzzo, Marco; Bimbatti, Davide; Claps, Melanie; Maiorano, Brigida Anna; Vitale, Maria Giuseppa; Iacovelli, Roberto; Ermacora, Paola; Roviello, Giandomenico; Calabrò, Fabio; Caffo, Orazio; Vignani, Francesca; Grillone, Francesco; Pierantoni, Francesco; Napoli, Marilena Di; Mennitto, Alessia; Marchetti, Andrea; Mattana, Alvise; Cavo, Alessia; Bassanelli, Maria; Formisano, Luigi; Prati, Veronica; Giudice, Giulia Claire; Buti, Sebastiano
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy
2024 De Giglio, Andrea; Leonetti, Alessandro; Comito, Francesca; Filippini, Daria Maria; Mollica, Veronica; Rihawi, Karim; Peroni, Marianna; Mazzaschi, Giulia; Ricciotti, Ilaria; Carosi, Francesca; Marchetti, Andrea; Rosellini, Matteo; Gagliano, Ambrogio; Favorito, Valentina; Nobili, Elisabetta; Gelsomino, Francesco; Melotti, Barbara; Marchese, Paola Valeria; Sperandi, Francesca; Di Federico, Alessandro; Buti, Sebastiano; Perrone, Fabiana; Massari, Francesco; Pantaleo, Maria Abbondanza; Tiseo, Marcello; Ardizzoni, Andrea
Do we need alternative PD-1 inhibitors for the treatment of renal cell carcinoma?
2024 Rosellini, Matteo; Marchetti, Andrea; Tassinari, Elisa; Mollica, Veronica; Massari, Francesco; Santoni, Matteo
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study
2024 Massari, Francesco; Santoni, Matteo; Takeshita, Hideki; Okada, Yohei; Tapia, Jose Carlos; Basso, Umberto; Maruzzo, Marco; Scagliarini, Sarah; Büttner, Thomas; Fornarini, Giuseppe; Myint, Zin W; Galli, Luca; Souza, Vinicius Carrera; Pichler, Renate; De Giorgi, Ugo; Gandur, Nathalia; Lam, Elaine T; Gilbert, Danielle; Popovic, Lazar; Grande, Enrique; Mammone, Giulia; Berardi, Rossana; Crabb, Simon J; Kemp, Robert; Molina-Cerrillo, Javier; Freitas, Marcelo; Luz, Murilo; Iacovelli, Roberto; Calabrò, Fabio; Tural, Deniz; Atzori, Francesco; Küronya, Zsófia; Chiari, Rita; Campos, Saul; Caffo, Orazio; Fay, André P; Kucharz, Jakub; Zucali, Paolo Andrea; Rinck, José Augusto; Zeppellini, Annalisa; Bastos, Diogo Assed; Aurilio, Gaetano; Mota, Augusto; Trindade, Karine; Ortega, Cinzia; Sade, Juan Pablo; Rizzo, Mimma; Fiala, Ondřej; Vau, Nuno; Giannatempo, Patrizia; Barillas, Allan; Monteiro, Fernando Sabino M; Dauster, Breno; Mennitto, Alessia; Nogueira, Lucas; de Carvalho Fernandes, Roni; Seront, Emmanuel; Aceituno, Luís Garcia; Grillone, Francesco; Cutuli, Hernan Javier; Fernandez, Mauricio; Bassanelli, Maria; Kopp, Ray Manneh; Roviello, Giandomenico; Abahssain, Halima; Procopio, Giuseppe; Milella, Michele; Kopecky, Jindrich; Martignetti, Angelo; Messina, Carlo; Caitano, Manuel; Inman, Eva; Kanesvaran, Ravindran; Herchhorn, Daniel; Santini, Daniele; Bamias, Aristotelis; Bisonni, Renato; Mosca, Alessandra; Morelli, Franco; Maluf, Fernando; Soares, Andrey; Nunes, Fernando; Pinto, Alvaro; Zgura, Anca; Incorvaia, Lorena; Ansari, Jawaher; Zabalza, Ignacio Ortego; Landmesser, Johannes; Rizzo, Alessandro; Mollica, Veronica; Marchetti, Andrea; Rosellini, Matteo; Sorgentoni, Giulia; Battelli, Nicola; Buti, Sebastiano; Porta, Camillo; Bellmunt, Joaquim
Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives
2024 Compagno, Samuele; Casadio, Chiara; Galvani, Linda; Rosellini, Matteo; Marchetti, Andrea; Tassinari, Elisa; Piazza, Pietro; Mottaran, Angelo; Santoni, Matteo; Schiavina, Riccardo; Massari, Francesco; Mollica, Veronica
Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1)
2024 Santini, Daniele; Li, Haoran; Roviello, Giandomenico; Park, Se Hoon; Grande, Enrique; Kucharz, Jakub; Basso, Umberto; Fiala, Ondrej; Monteiro, Fernando Sabino Marques; Poprach, Alexandr; Buti, Sebastiano; Molina-Cerrillo, Javier; Catalano, Martina; Buchler, Tomas; Seront, Emmanuel; Ansari, Jawaher; Myint, Zin W; Ghosn, Marwan; Calabrò, Fabio; Kopp, Ray Manneh; Bhuva, Dipen; Bourlon, Maria T; Roberto, Michela; Di Civita, Mattia Alberto; Mollica, Veronica; Marchetti, Andrea; Soares, Andrey; Battelli, Nicola; Ricci, Marco; Kanesvaran, Ravindran; Bamias, Aristotelis; Porta, Camillo; Massari, Francesco; Santoni, Matteo
Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma
2024 Mollica, Veronica; Rosellini, Matteo; Brocchi, Stefano; Galuppi, Francesco; Paccapelo, Alexandro; Tateo, Valentina; Marchetti, Andrea; Tassinari, Elisa; Mantuano, Francesco; Santoni, Matteo; Massari, Francesco
What is the risk of hepatotoxicity induced by immune-checkpoint inhibitors and how can we avoid it?
2024 Tassinari, Elisa; Rosellini, Matteo; Marchetti, Andrea; Mollica, Veronica; Massari, Francesco
Adapting to hormone-therapy resistance for adopting the right therapeutic strategy in advanced prostate cancer
2023 Nuvola, Giacomo; Santoni, Matteo; Rizzo, Mimma; Rosellini, Matteo; Mollica, Veronica; Rizzo, Alessandro; Marchetti, Andrea; Battelli, Nicola; Massari, Francesco
An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma
2023 Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Tateo, Valentina; Nuvola, Giacomo; Rizzo, Alessandro; Massari, Francesco; Mollica, Veronica
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis
2023 Santoni, Matteo; Rizzo, Alessandro; Kucharz, Jakub; Mollica, Veronica; Rosellini, Matteo; Marchetti, Andrea; Tassinari, Elisa; Monteiro, Fernando Sabino Marques; Soares, Andrey; Molina-Cerrillo, Javier; Grande, Enrique; Battelli, Nicola; Massari, Francesco
How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma?
2023 Conci, Nicole; Tassinari, Elisa; Tateo, Valentina; Rosellini, Matteo; Marchetti, Andrea; Ricci, Costantino; Chessa, Francesco; Santoni, Matteo; Grande, Enrique; Mollica, Veronica; Massari, Francesco
Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study
2023 Rizzo, Alessandro; Mollica, Veronica; Tateo, Valentina; Tassinari, Elisa; Marchetti, Andrea; Rosellini, Matteo; De Luca, Raffaele; Santoni, Matteo; Massari, Francesco
Hypertransaminasemia in metastatic renal cell carcinoma patients receiving immune-based combinations: a meta-analysis
2023 Rizzo, Alessandro; Nuvola, Giacomo; Palmiotti, Gennaro; Ahcene-Djaballah, Selma; Mollica, Veronica; Rosellini, Matteo; Marchetti, Andrea; Nigro, Maria Concetta; Tassinari, Elisa; Macrini, Sveva; Massari, Francesco
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma
2023 Matteo Rosellini; Andrea Marchetti; Veronica Mollica; Alessandro Rizzo; Matteo Santoni; Francesco Massari
Prostate cancer and novel pharmacological treatment options - what's new for 2022?
2023 Marchetti, Andrea; Tassinari, Elisa; Rosellini, Matteo; Rizzo, Alessandro; Massari, Francesco; Mollica, Veronica
Re: Atezolizumab Plus Cabozantinib Versus Cabozantinib Monotherapy for Patients with Renal Cell Carcinoma After Progression with Previous Immune Checkpoint Inhibitor Treatment (CONTACT-03): A Multicentre, Randomised, Open-label, Phase 3 Trial
2023 Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Mollica, Veronica; Massari, Francesco
TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab
2023 Mollica, Veronica; Tassinari, Elisa; Santoni, Matteo; Marchese, Paola Valeria; Giunchi, Francesca; Maloberti, Thais; Tateo, Valentina; Ricci, Costantino; Rosellini, Matteo; Marchetti, Andrea; Fiorentino, Michelangelo; Biase, Dario De; Massari, Francesco
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
A prospective study on the early evaluation of response to androgen receptor-targeted agents with 11C-Choline, 68Ga-PSMA, and 18F-FACBC PET in metastatic castration-resistant prostate cancer: a single-center experience | Mollica, V.; Marchetti, A.; Fraccascia, N.; Nanni, C.; Tabacchi, E.; Malizia, C.; Argalia, G.; Ro...sellini, M.; Tassinari, E.; Paccapelo, A.; Fanti, S.; Massari, F. | 2024-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | ESMO Open 2024.pdf; appendix.docx |
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis | Rosellini, Matteo; Mollica, Veronica; Marchetti, Andrea; Coluccelli, Sara; Giunchi, Francesca; Ta...ssinari, Elisa; Ricci, Costantino; Fiorentino, Michelangelo; Tallini, Giovanni; De Biase, Dario; Massari, Francesco | 2024-01-01 | PATHOLOGY, RESEARCH AND PRACTICE | - | 1.01 Articolo in rivista | - |
Clinical outcomes and prognostic factors in patients with penile carcinoma: a sub-analysis from Meet-URO 23 (I-RARE) registry study | Mollica, Veronica; Massari, Francesco; Maruzzo, Marco; Bimbatti, Davide; Claps, Melanie; Maiorano..., Brigida Anna; Vitale, Maria Giuseppa; Iacovelli, Roberto; Ermacora, Paola; Roviello, Giandomenico; Calabrò, Fabio; Caffo, Orazio; Vignani, Francesca; Grillone, Francesco; Pierantoni, Francesco; Napoli, Marilena Di; Mennitto, Alessia; Marchetti, Andrea; Mattana, Alvise; Cavo, Alessia; Bassanelli, Maria; Formisano, Luigi; Prati, Veronica; Giudice, Giulia Claire; Buti, Sebastiano | 2024-01-01 | CLINICAL GENITOURINARY CANCER | - | 1.01 Articolo in rivista | - |
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy | De Giglio, Andrea; Leonetti, Alessandro; Comito, Francesca; Filippini, Daria Maria; Mollica, Vero...nica; Rihawi, Karim; Peroni, Marianna; Mazzaschi, Giulia; Ricciotti, Ilaria; Carosi, Francesca; Marchetti, Andrea; Rosellini, Matteo; Gagliano, Ambrogio; Favorito, Valentina; Nobili, Elisabetta; Gelsomino, Francesco; Melotti, Barbara; Marchese, Paola Valeria; Sperandi, Francesca; Di Federico, Alessandro; Buti, Sebastiano; Perrone, Fabiana; Massari, Francesco; Pantaleo, Maria Abbondanza; Tiseo, Marcello; Ardizzoni, Andrea | 2024-01-01 | CANCER IMMUNOLOGY, IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
Do we need alternative PD-1 inhibitors for the treatment of renal cell carcinoma? | Rosellini, Matteo; Marchetti, Andrea; Tassinari, Elisa; Mollica, Veronica; Massari, Francesco; Sa...ntoni, Matteo | 2024-01-01 | EXPERT OPINION ON BIOLOGICAL THERAPY | - | 1.01 Articolo in rivista | - |
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study | Massari, Francesco; Santoni, Matteo; Takeshita, Hideki; Okada, Yohei; Tapia, Jose Carlos; Basso, ...Umberto; Maruzzo, Marco; Scagliarini, Sarah; Büttner, Thomas; Fornarini, Giuseppe; Myint, Zin W; Galli, Luca; Souza, Vinicius Carrera; Pichler, Renate; De Giorgi, Ugo; Gandur, Nathalia; Lam, Elaine T; Gilbert, Danielle; Popovic, Lazar; Grande, Enrique; Mammone, Giulia; Berardi, Rossana; Crabb, Simon J; Kemp, Robert; Molina-Cerrillo, Javier; Freitas, Marcelo; Luz, Murilo; Iacovelli, Roberto; Calabrò, Fabio; Tural, Deniz; Atzori, Francesco; Küronya, Zsófia; Chiari, Rita; Campos, Saul; Caffo, Orazio; Fay, André P; Kucharz, Jakub; Zucali, Paolo Andrea; Rinck, José Augusto; Zeppellini, Annalisa; Bastos, Diogo Assed; Aurilio, Gaetano; Mota, Augusto; Trindade, Karine; Ortega, Cinzia; Sade, Juan Pablo; Rizzo, Mimma; Fiala, Ondřej; Vau, Nuno; Giannatempo, Patrizia; Barillas, Allan; Monteiro, Fernando Sabino M; Dauster, Breno; Mennitto, Alessia; Nogueira, Lucas; de Carvalho Fernandes, Roni; Seront, Emmanuel; Aceituno, Luís Garcia; Grillone, Francesco; Cutuli, Hernan Javier; Fernandez, Mauricio; Bassanelli, Maria; Kopp, Ray Manneh; Roviello, Giandomenico; Abahssain, Halima; Procopio, Giuseppe; Milella, Michele; Kopecky, Jindrich; Martignetti, Angelo; Messina, Carlo; Caitano, Manuel; Inman, Eva; Kanesvaran, Ravindran; Herchhorn, Daniel; Santini, Daniele; Bamias, Aristotelis; Bisonni, Renato; Mosca, Alessandra; Morelli, Franco; Maluf, Fernando; Soares, Andrey; Nunes, Fernando; Pinto, Alvaro; Zgura, Anca; Incorvaia, Lorena; Ansari, Jawaher; Zabalza, Ignacio Ortego; Landmesser, Johannes; Rizzo, Alessandro; Mollica, Veronica; Marchetti, Andrea; Rosellini, Matteo; Sorgentoni, Giulia; Battelli, Nicola; Buti, Sebastiano; Porta, Camillo; Bellmunt, Joaquim | 2024-01-01 | CANCER IMMUNOLOGY, IMMUNOTHERAPY | - | 1.01 Articolo in rivista | Cancer Immunology Immunotherapy 2024 [ARON2 Pembro].pdf; 262_2024_3682_MOESM1_ESM.docx |
Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives | Compagno, Samuele; Casadio, Chiara; Galvani, Linda; Rosellini, Matteo; Marchetti, Andrea; Tassina...ri, Elisa; Piazza, Pietro; Mottaran, Angelo; Santoni, Matteo; Schiavina, Riccardo; Massari, Francesco; Mollica, Veronica | 2024-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | - |
Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1) | Santini, Daniele; Li, Haoran; Roviello, Giandomenico; Park, Se Hoon; Grande, Enrique; Kucharz, Ja...kub; Basso, Umberto; Fiala, Ondrej; Monteiro, Fernando Sabino Marques; Poprach, Alexandr; Buti, Sebastiano; Molina-Cerrillo, Javier; Catalano, Martina; Buchler, Tomas; Seront, Emmanuel; Ansari, Jawaher; Myint, Zin W; Ghosn, Marwan; Calabrò, Fabio; Kopp, Ray Manneh; Bhuva, Dipen; Bourlon, Maria T; Roberto, Michela; Di Civita, Mattia Alberto; Mollica, Veronica; Marchetti, Andrea; Soares, Andrey; Battelli, Nicola; Ricci, Marco; Kanesvaran, Ravindran; Bamias, Aristotelis; Porta, Camillo; Massari, Francesco; Santoni, Matteo | 2024-01-01 | TARGETED ONCOLOGY | - | 1.01 Articolo in rivista | - |
Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma | Mollica, Veronica; Rosellini, Matteo; Brocchi, Stefano; Galuppi, Francesco; Paccapelo, Alexandro;... Tateo, Valentina; Marchetti, Andrea; Tassinari, Elisa; Mantuano, Francesco; Santoni, Matteo; Massari, Francesco | 2024-01-01 | EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT | - | 1.01 Articolo in rivista | ERPMDD 2024 [TGR].pdf |
What is the risk of hepatotoxicity induced by immune-checkpoint inhibitors and how can we avoid it? | Tassinari, Elisa; Rosellini, Matteo; Marchetti, Andrea; Mollica, Veronica; Massari, Francesco | 2024-01-01 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | - | 1.01 Articolo in rivista | - |
Adapting to hormone-therapy resistance for adopting the right therapeutic strategy in advanced prostate cancer | Nuvola, Giacomo; Santoni, Matteo; Rizzo, Mimma; Rosellini, Matteo; Mollica, Veronica; Rizzo, Ales...sandro; Marchetti, Andrea; Battelli, Nicola; Massari, Francesco | 2023-01-01 | EXPERT REVIEW OF ANTICANCER THERAPY | - | 1.01 Articolo in rivista | - |
An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma | Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Tateo, Valentina; Nuvola, Giacomo; Rizzo,... Alessandro; Massari, Francesco; Mollica, Veronica | 2023-01-01 | EXPERT OPINION ON DRUG SAFETY | - | 1.01 Articolo in rivista | - |
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis | Santoni, Matteo; Rizzo, Alessandro; Kucharz, Jakub; Mollica, Veronica; Rosellini, Matteo; Marchet...ti, Andrea; Tassinari, Elisa; Monteiro, Fernando Sabino Marques; Soares, Andrey; Molina-Cerrillo, Javier; Grande, Enrique; Battelli, Nicola; Massari, Francesco | 2023-01-01 | CANCER IMMUNOLOGY, IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma? | Conci, Nicole; Tassinari, Elisa; Tateo, Valentina; Rosellini, Matteo; Marchetti, Andrea; Ricci, C...ostantino; Chessa, Francesco; Santoni, Matteo; Grande, Enrique; Mollica, Veronica; Massari, Francesco | 2023-01-01 | MOLECULAR DIAGNOSIS & THERAPY | - | 1.01 Articolo in rivista | Molecular Diagn Ther 2023 [Neoadj UC].pdf |
Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study | Rizzo, Alessandro; Mollica, Veronica; Tateo, Valentina; Tassinari, Elisa; Marchetti, Andrea; Rose...llini, Matteo; De Luca, Raffaele; Santoni, Matteo; Massari, Francesco | 2023-01-01 | CANCER IMMUNOLOGY, IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
Hypertransaminasemia in metastatic renal cell carcinoma patients receiving immune-based combinations: a meta-analysis | Rizzo, Alessandro; Nuvola, Giacomo; Palmiotti, Gennaro; Ahcene-Djaballah, Selma; Mollica, Veronic...a; Rosellini, Matteo; Marchetti, Andrea; Nigro, Maria Concetta; Tassinari, Elisa; Macrini, Sveva; Massari, Francesco | 2023-01-01 | IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma | Matteo Rosellini; Andrea Marchetti; Veronica Mollica; Alessandro Rizzo; Matteo Santoni; Francesco... Massari | 2023-01-01 | NATURE REVIEWS. UROLOGY | - | 1.01 Articolo in rivista | Manuscript (clean copy).docx |
Prostate cancer and novel pharmacological treatment options - what's new for 2022? | Marchetti, Andrea; Tassinari, Elisa; Rosellini, Matteo; Rizzo, Alessandro; Massari, Francesco; Mo...llica, Veronica | 2023-01-01 | EXPERT REVIEW OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
Re: Atezolizumab Plus Cabozantinib Versus Cabozantinib Monotherapy for Patients with Renal Cell Carcinoma After Progression with Previous Immune Checkpoint Inhibitor Treatment (CONTACT-03): A Multicentre, Randomised, Open-label, Phase 3 Trial | Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Mollica, Veronica; Massari, Francesco | 2023-01-01 | EUROPEAN UROLOGY | - | 1.01 Articolo in rivista | - |
TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab | Mollica, Veronica; Tassinari, Elisa; Santoni, Matteo; Marchese, Paola Valeria; Giunchi, Francesca...; Maloberti, Thais; Tateo, Valentina; Ricci, Costantino; Rosellini, Matteo; Marchetti, Andrea; Fiorentino, Michelangelo; Biase, Dario De; Massari, Francesco | 2023-01-01 | PATHOLOGY RESEARCH AND PRACTICE | - | 1.01 Articolo in rivista | - |